 |
|
Home | SunTrust Starts Coverage on Optimer Pharmaceutic (OPTR) |
 |
SunTrust Starts Coverage on Optimer Pharmaceutic (OPTR)
|
 |
- June 15, 2012
-
Equities researchers at SunTrust began coverage on shares of Optimer Pharmaceutic (NASDAQ: OPTR) in a report issued on Friday. The firm set a “buy” rating on the stock. Shares of Optimer Pharmaceutic opened at 15.37 on Friday. Optimer Pharmaceutic has a 52 week low of $6.81 and a 52 week high of $17.95. The company’s [...]This article (SunTrust Starts Coverage on Optimer Pharmaceutic (OPTR)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2012/06/15/suntrust-starts-coverage-on-optimer-pharmaceutic-optr/
|
 |
|
 |
|
 |
